|
Volumn 139, Issue 5, 2002, Pages 268-273
|
At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor);Enfin un traitement efficace dans les sarcomes digestifs indifférenciés (tumeurs stromales).
a a a
a
INSTITUT CURIE
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
STEM CELL FACTOR RECEPTOR;
ADULT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
DRUG ANTAGONISM;
DRUG RESISTANCE;
GASTROINTESTINAL TUMOR;
GENETICS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LEIOMYOSARCOMA;
MIDDLE AGED;
MUTATION;
PATHOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SARCOMA;
STOMACH;
STOMACH TUMOR;
TIME;
ADULT;
ANTINEOPLASTIC AGENTS;
DIAGNOSIS, DIFFERENTIAL;
DRUG RESISTANCE, NEOPLASM;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LEIOMYOSARCOMA;
MIDDLE AGED;
MUTATION;
PIPERAZINES;
PROGNOSIS;
PROTEIN-TYROSINE KINASES;
PROTO-ONCOGENE PROTEINS C-KIT;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS;
SARCOMA;
STOMACH;
STOMACH NEOPLASMS;
TIME FACTORS;
|
EID: 0347788956
PISSN: 00217697
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (18)
|